Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease Evaluation Using 8-Color Flow Cytometry Predicts Risk of Relapse in High-Risk and/or Young Myeloma Patients Who Receive Bortezomib Consolidation after Frontline Tandem Transplantation

Richard Leblanc, MD FRCPC, Imran Ahmad, MD MPH, Rafik Terra, PhD, Séverine Landais, PhD, Céline Nkoue, MD, Michael Sebag, MD PhD, Émilie Lemieux Blanchard, MD FRCPC, Nadia M. Bambace, MD, Léa Bernard, MD, Sandra Cohen, MD FRCP(C), Jean-Sébastien Delisle, MD PhD, Thomas L. Kiss, MD, Silvy Lachance, MD FRCP, Denis-Claude Roy, MD, Guy Sauvageau, MD, PhD, Jean Roy, MD

Blood (2018) 132 (Supplement 1): 4666.

https://doi.org/10.1182/blood-2018-99-112313

Published: 2018

Journal Articles

Bortezomib Consolidation after Nonmyeloablative Allogeneic Transplant Is Safe and Leads to a High Incidence of Immunophenotypic Complete Response in High-Risk or Young Myeloma Patients

Richard LeBlanc, MDFRCPC, Imran Ahmad, MD M.Sc., Rafik Terra, PhD, Séverine Landais, PhD, Michael Sebag, MD PhD, Emilie Lemieux-Blanchard, MD, Nadia M. Bambace, MD, Léa Bernard, MD, Sandra Cohen, MD, Jean-Sébastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MDFRCPC, Denis-Claude Roy, MD, Guy Sauvageau, MD PhD, Jean Roy, MD

Blood (2017) 130 (Supplement 1): 4556.

https://doi.org/10.1182/blood.V130.Suppl_1.4556.4556

Published: 2017

Journal Articles

Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients

Richard LeBlanc, MD, Imran Ahmad, MD, Rafik Terra, PhD, Séverine Landais, PhD, Michael Sebag, MD PhD, Emilie Lemieux-Blanchard, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Guy Sauvageau, MD PhD, Jean Roy, MD

Blood (2016) 128 (22): 2306.

https://doi.org/10.1182/blood.V128.22.2306.2306

Published: 2016

Journal Articles

Impact of Normalized Free Light Chain Ratio for Assessment of Monoclonal Protein in Patients with Light Chain Only and Oligosecretory Myeloma

Kentaro Narita, MD, Yoshiaki Usui, MD, Yoshiaki Abe, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2016) 128 (22): 2074.

https://doi.org/10.1182/blood.V128.22.2074.2074

Published: 2016

Journal Articles

Development of a Novel Phthalimide Derivative, Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts

Yutaka Hattori, MD PhD, Maiko Matsushita, MD PhD, Noriko Tabata, Hirokazu Shiheido, Hiroshi Yanagawa, PhD, Arimi Ueda, Masashi Hozumi, Shotaro Kitabatake, Daiju Ichikawa

Blood (2014) 124 (21): 5718.

https://doi.org/10.1182/blood.V124.21.5718.5718

Published: 2014

Journal Articles

A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy Against Anemia Of Chronic Disease

Tohru Fujiwara, MD, PhD, Takashi Ikeda, Yuki Nagasaka, Yoko Okitsu, MD, PhD, Noriko Fukuhara, MD, PhD, Yasushi Onishi, MD, PhD, Kenichi Ishizawa, MD, Ryo Ichinohasama, MD, PhD, Naohisa Tomosugi, MD, PhD, Hideo Harigae, MD, PhD

Blood (2013) 122 (21): 3436.

https://doi.org/10.1182/blood.V122.21.3436.3436

Published: 2013

Journal Articles

Heparanase Activation of the Coagulation System in a Mice Sepsis Model

Israel Henig, MD, Elena Axelman, MSc., Benjamin Brenner, MD, Israel Vlodavsky, Ph.D, Yona Nadir, M.D., Ph.D

Blood (2011) 118 (21): 378.

https://doi.org/10.1182/blood.V118.21.378.378

Published: 2011

Journal Articles

Study on Transportation of Arsenic Trioxide Nanoparticles Across Blood-Brain Barrier in ICR Mice

Ji ying Shan, Ning Ma, Jr., Long Su, Sr., Wei Li, Ziling Liu

Blood (2011) 118 (21): 4292.

https://doi.org/10.1182/blood.V118.21.4292.4292

Published: 2011

Journal Articles

Significance of Minimal Residual Disease Monitored by Quantitative Assessment of WT1gene in Patients in First Remission of Acute Myeloid Leukemia Before Allogeneic Stem Cell Transplantation

Veronika Válková, Jaroslav Polak, Marketa Markova, Hana Hájková, Antonin Vitek, Mariana Hricinová, Dana Mikulenková, Jaroslav Cermak, MD, PhD, Petr Cetkovsky

Blood (2011) 118 (21): 4485.

https://doi.org/10.1182/blood.V118.21.4485.4485

Published: 2011

Journal Articles

Low-Dose Rituximab In Idiopathic Autoimmune Hemolytic Anemia: Biological Studies

Wilma Barcellini, Francesco Zaja, Anna Zaninoni, Francesca Guia Imperiali, Marta Lisa Battista, Eros Di Bona, Dario Consonni, Alberto Zanella, MD

Blood (2010) 116 (21): 3206.

https://doi.org/10.1182/blood.V116.21.3206.3206

Published: 2010

Journal Articles

Influence of Magnetic Fe 3 O 4 Nanoparticle On the Lymphocyte and Macrophage Function of Mice.

Bao-An Chen, Nan Jin, Jun Wang, Jia-Hua Ding, Chong Gao, Jian Cheng, Ning-Na Chen, Gang Zhao, Xue-Mei Wang, Xiao-Ping Pei

Blood (2009) 114 (22): 4519.

https://doi.org/10.1182/blood.V114.22.4519.4519

Published: 2009

Journal Articles

Low-Dose Rituximab in Idiopathic Autoimmune Hemolytic Anemia.

Wilma Barcellini, Francesco Zaja, Anna Zaninoni, Francesca Guia Imperiali, Marta Battista, Carla Filí, Domenico Russo, Eros Di Bona, Dario Consonni, Alberto Zanella

Blood (2009) 114 (22): 4027.

https://doi.org/10.1182/blood.V114.22.4027.4027

Published: 2009

NARROW

Minimal Residual Disease Evaluation Using 8-Color Flow Cytometry Predicts Risk of Relapse in High-Risk and/or Young Myeloma Patients Who Receive Bortezomib Consolidation after Frontline Tandem Transplantation

Bortezomib Consolidation after Nonmyeloablative Allogeneic Transplant Is Safe and Leads to a High Incidence of Immunophenotypic Complete Response in High-Risk or Young Myeloma Patients

Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients

Impact of Normalized Free Light Chain Ratio for Assessment of Monoclonal Protein in Patients with Light Chain Only and Oligosecretory Myeloma

Development of a Novel Phthalimide Derivative, Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts

A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy Against Anemia Of Chronic Disease

Heparanase Activation of the Coagulation System in a Mice Sepsis Model

Study on Transportation of Arsenic Trioxide Nanoparticles Across Blood-Brain Barrier in ICR Mice

Significance of Minimal Residual Disease Monitored by Quantitative Assessment of WT1gene in Patients in First Remission of Acute Myeloid Leukemia Before Allogeneic Stem Cell Transplantation

Low-Dose Rituximab In Idiopathic Autoimmune Hemolytic Anemia: Biological Studies

Influence of Magnetic Fe 3 O 4 Nanoparticle On the Lymphocyte and Macrophage Function of Mice.

Low-Dose Rituximab in Idiopathic Autoimmune Hemolytic Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only